Treatment of hyperkalemia: Something old, something new

Kidney International

Volumn 89, Issue 3, 2016, Pages 546-554

  Sterns, Richard H ^a,b   Grieff, Marvin ^a,b   Bernstein, Paul L ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b ROCHESTER GENERAL HOSPITAL   (United States)

Author keywords

cation exchange resins; hyperkalemia; insulin; potassium; renal dialysis; sodium bicarbonate

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BICARBONATE; CALCINEURIN INHIBITOR; CALCIUM CHLORIDE; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUDROCORTISONE; GLUCONATE CALCIUM; GLUCOSE; HEPARIN; INSULIN; INSULIN ASPART; INSULIN LISPRO; LACTATE SODIUM; LOOP DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PATIROMER; PLACEBO; POLYSTYRENESULFONATE SODIUM; POTASSIUM; POTASSIUM SPARING DIURETIC AGENT; SALBUTAMOL; SODIUM; SODIUM ZIRCONIUM CYCLOSILICATE; SORBITOL; TERBUTALINE; TRIMETHOPRIM; UNINDEXED DRUG; BIOLOGICAL MARKER; CATION EXCHANGE RESIN; CHELATING AGENT; DIURETIC AGENT;

BLOOD ANALYSIS; COLON PERFORATION; CONSTIPATION; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL (TOPIC); DISEASE SEVERITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG TOLERABILITY; EDEMA; GASTROINTESTINAL DISEASE; HEMODIALYSIS; HUMAN; HYPERKALEMIA; HYPOCALCEMIA; HYPOGLYCEMIA; HYPOMAGNESEMIA; INTESTINE OBSTRUCTION; KIDNEY DISEASE; KIDNEY FUNCTION; LONG TERM CARE; MEDICAL DECISION MAKING; METABOLIC ACIDOSIS; MULTICENTER STUDY (TOPIC); NAUSEA; PATIENT SELECTION; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; SODIUM RETENTION; ANIMAL; BLOOD; DOWN REGULATION; TREATMENT OUTCOME;

ANIMALS; BIOMARKERS; CATION EXCHANGE RESINS; CHELATING AGENTS; DIURETICS; DOWN-REGULATION; HUMANS; HYPERKALEMIA; POTASSIUM; TREATMENT OUTCOME;

EID: 84964478074     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2015.11.018     Document Type: Review

References (128)

1. R.B. Flinn, J.P. Merrill, and W.R. Welzant Treatment of the oliguric patient with a new sodium-exchange resin and sorbitol: a preliminary report N Engl J Med 264 1961 111 115
2. Anonymous. Treatment of potassium retention N Engl J Med 264 1961 149 150
3. L. Scherr, D.A. Ogden, A.W. Mead, and et al. Management of hyperkalemia with a cation-exchange resin N Engl J Med 264 1961 115 119
4. R.H. Sterns, M. Rojas, P. Bernstein, and S. Chennupati Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective? J Am Soc Nephrol 21 2010 733 735
5. N.G. Levinsky Management of emergencies. VI. Hyperkalemia N Engl J Med 274 1966 1076 1077
6. J.P. Merrill, H.D. Levine, W. Somerville, and S. Smith Clinical recognition and treatment of acute potassium intoxication Ann Intern Med 33 1950 797 830
7. M.J. Elliott, P.E. Ronksley, C.M. Clase, and et al. Management of patients with acute hyperkalemia CMAJ 182 2010 1631 1635
8. K.S. Kamel, and C. Wei Controversial issues in the treatment of hyperkalaemia Nephrol Dial Transplant 18 2003 2215 2218
9. B.A. Mahoney, W.A. Smith, D.S. Lo, and et al. Emergency interventions for hyperkalaemia Cochrane Database Syst Rev 2 2005 CD003235
10. J.R. Ingelfinger A new era for the treatment of hyperkalemia? N Engl J Med 372 2015 275 277
11. M.L. Gumz, L. Rabinowitz, and C.S. Wingo An integrated view of potassium homeostasis N Engl J Med 373 2015 60 72
12. A. Yang, B. Singh, P.T. Lavin, and et al. Placebo effect in clinical studies in hyperkalemia: a double-blind, randomized, placebo-controlled phase 3 study of sodium zirconium cyclosilicate (ZS-9) [Abstract] Am J Kidney Dis 65 2015 A91
13. M.L. Gumz, and L. Rabinowitz Role of circadian rhythms in potassium homeostasis Semin Nephrol 33 2013 229 236
14. S.T. Schmidt, T. Ditting, B. Deutsch, and et al. Circadian rhythm and day to day variability of serum potassium concentration: a pilot study J Nephrol 28 2015 165 172
15. Q.H. Meng, and E.A. Wagar Pseudohyperkalemia: a new twist on an old phenomenon Crit Rev Clin Lab Sci 52 2015 45 55
16. M.J. Bia, and R.A. DeFronzo Extrarenal potassium homeostasis Am J Physiol 240 1981 F257 268
17. M. Graber, K. Subramani, D. Corish, and A. Schwab Thrombocytosis elevates serum potassium Am J Kidney Dis 12 1988 116 120
18. B.R. Don, A. Sebastian, M. Cheitlin, and et al. Pseudohyperkalemia caused by fist clenching during phlebotomy N Engl J Med 322 1990 1290 1292
19. M. Seimiya, T. Yoshida, Y. Sawabe, and et al. Reducing the incidence of pseudohyperkalemia by avoiding making a fist during phlebotomy: a quality improvement report Am J Kidney Dis 56 2010 686 692
20. I.R. Bailey, and V.R. Thurlow Is suboptimal phlebotomy technique impacting on potassium results for primary care? Ann Clin Biochem 45 2008 266 269
21. V. Thurlow, H. Ozevlat, S.A. Jones, and I.R. Bailey Establishing a practical blood platelet threshold to avoid reporting spurious potassium results due to thrombocytosis Ann Clin Biochem 42 2005 196 199
22. N.R. Chawla, J. Shapiro, and R.L. Sham Pneumatic tube "pseudo tumor lysis syndrome" in chronic lymphocytic leukemia Am J Hematol 84 2009 613 614
23. P.S. Kellerman, and J.M. Thornbery Pseudohyperkalemia due to pneumatic tube transport in a leukemic patient Am J Kidney Dis 46 2005 746 748
24. S.K. Sindhu, J.K. Hix, and W. Fricke Pseudohyperkalemia in chronic lymphocytic leukemia: phlebotomy sites and pneumatic tubes Am J Kidney Dis 57 2011 354 355
25. W.A. Parham, A.A. Mehdirad, K.M. Biermann, and C.S. Fredman Hyperkalemia revisited Tex Heart Inst J 33 2006 40 47
26. T. Bashour, I. Hsu, H.J. Gorfinkel, and et al. Atrioventricular and intraventricular conduction in hyperkalemia Am J Cardiol 35 1975 199 203
27. P.O. Ettinger, T.J. Regan, and H.A. Oldewurtel Hyperkalemia, cardiac conduction, and the electrocardiogram: a review Am Heart J 88 1974 360 371
28. P.A. McCullough, T.M. Beaver, E. Bennett-Guerrero, and et al. Acute and chronic cardiovascular effects of hyperkalemia: new insights into prevention and clinical management Rev Cardiovasc Med 15 2014 11 23
29. A. Mattu, W.J. Brady, and D.A. Robinson Electrocardiographic manifestations of hyperkalemia Am J Emerg Med 18 2000 721 729
30. K.D. Wrenn, C.M. Slovis, and B.S. Slovis The ability of physicians to predict hyperkalemia from the ECG Ann Emerg Med 20 1991 1229 1232
31. S. Aslam, E.A. Friedman, and O. Ifudu Electrocardiography is unreliable in detecting potentially lethal hyperkalaemia in haemodialysis patients Nephrol Dial Transplant 17 2002 1639 1642
32. H.K. Khattak, S. Khalid, K. Manzoor, and P.K. Stein Recurrent life-threatening hyperkalemia without typical electrocardiographic changes J Electrocardiol 47 2014 95 97
33. A. Martinez-Vea, A. Bardaji, C. Garcia, and J.A. Oliver Severe hyperkalemia with minimal electrocardiographic manifestations: a report of seven cases J Electrocardiol 32 1999 45 49
34. H.M. Szerlip, J. Weiss, and I. Singer Profound hyperkalemia without electrocardiographic manifestations Am J Kidney Dis 7 1986 461 465
35. S.B. Chon, Y.H. Kwak, S.S. Hwang, and et al. Severe hyperkalemia can be detected immediately by quantitative electrocardiography and clinical history in patients with symptomatic or extreme bradycardia: a retrospective cross-sectional study J Crit Care 28 2013 1112.e7 1112.e13
36. S.S. Barold, and B. Herweg The effect of hyperkalaemia on cardiac rhythm devices Europace 16 2014 467 476
37. M. Chamberlain Emergency treatment of hyperkalaemia Lancet 1 1964 464 467
38. M. Levine, H. Nikkanen, and D.J. Pallin The effects of intravenous calcium in patients with digoxin toxicity J Emerg Med 40 2011 41 46
39. K. Ho A critically swift response: insulin-stimulated potassium and glucose transport in skeletal muscle Clin J Am Soc Nephrol 6 2011 1513 1516
40. R.A. DeFronzo, P. Felig, E. Ferrannini, and J. Wahren Effect of graded doses of insulin on splanchnic and peripheral potassium metabolism in man Am J Physiol 238 1980 E421 427
41. R.A. DeFronzo, J.D. Tobin, and R. Andres Glucose clamp technique: a method for quantifying insulin secretion and resistance Am J Physiol 237 1979 G214 G223
42. A. Alvestrand, J. Wahren, D. Smith, and R.A. DeFronzo Insulin-mediated potassium uptake is normal in uremic and healthy subjects Am J Physiol 246 1984 E174 E180
43. T.Q. Nguyen, N.M. Maalouf, K. Sakhaee, and O.W. Moe Comparison of insulin action on glucose versus potassium uptake in humans Clin J Am Soc Nephrol 6 2011 1533 1539
44. J. Soar, G.D. Perkins, G. Abbas, and et al. European Resuscitation Council Guidelines for Resuscitation 2010 Section 8. Cardiac arrest in special circumstances: electrolyte abnormalities, poisoning, drowning, accidental hypothermia, hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, electrocution Resuscitation 81 2010 1400 1433
45. T.L. Vanden Hoek, L.J. Morrison, M. Shuster, and et al. Part 12: cardiac arrest in special situations: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Circulation 122 suppl 3 2010 S829 S861
46. M. Allon, and N. Shanklin Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol Am J Kidney Dis 28 1996 508 514
47. M. Allon, and C. Copkney Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients Kidney Int 38 1990 869 872
48. M.Y. Chothia, M.L. Halperin, M.A. Rensburg, and et al. Bolus administration of intravenous glucose in the treatment of hyperkalemia: a randomized controlled trial Nephron Physiol 126 2014 1 8
49. X.M. Lens, J. Montoliu, A. Cases, and et al. Treatment of hyperkalaemia in renal failure: salbutamol v. insulin Nephrol Dial Transplant 4 1989 228 232
50. D. Ljutic, and Z. Rumboldt Should glucose be administered before, with, or after insulin, in the management of hyperkalemia? Ren Fail 15 1993 73 76
51. M.A. Mushtaq, and M. Masood Treatment of hyperkalemia with salbutamol and insulin Pakistan J Med Sci 22 2006 176
52. N.N. Ngugi, S.O. McLigeyo, and J.K. Kayima Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches East Afr Med J 74 1997 503 509
53. M. Duranay, K. Ates, S. Erturk, and et al. Comparison of aminophylline and insulin infusions in treatment of hyperkalemia in patients with end-stage renal disease Nephron 73 1996 105
54. S.K. Mahajan, M. Mangla, and K. Kishore Comparison of aminophylline and insulin-dextrose infusions in acute therapy of hyperkalemia in end-stage renal disease patients J Assoc Physicians India 49 2001 1082 1085
55. H.J. Kim Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients Nephron 72 1996 476 482
56. A. Blumberg, P. Weidmann, and P. Ferrari Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure Kidney Int 41 1992 369 374
57. A. Blumberg, P. Weidmann, S. Shaw, and M. Gnädinger Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure Am J Med 85 1988 507 512
58. J.A. Galloway, C.T. Spradlin, R.L. Nelson, and et al. Factors influencing the absorption, serum insulin concentration, and blood glucose responses after injections of regular insulin and various insulin mixtures Diabetes Care 4 1981 366 376
59. S. Goldfarb, M. Cox, I. Singer, and M. Goldberg Acute hyperkalemia induced by hyperglycemia: hormonal mechanisms Ann Intern Med 84 1976 426 432
60. B.F. Palmer Regulation of potassium homeostasis Clin J Am Soc Nephrol 10 2015 1050 1060
61. P. Iglesias, and J.J. Díez Insulin therapy in renal disease Diabetes Obes Metab 10 2008 811 823
62. F. Bilotta, R. Badenes, S. Lolli, and et al. Insulin infusion therapy in critical care patients: regular insulin vs short-acting insulin. A prospective, crossover, randomized, multicenter blind study J Crit Care 30 2015 437.e1 437.e6
63. R.A. DeFronzo, A. Alvestrand, D. Smith, and et al. Insulin resistance in uremia J Clin Invest 67 1981 563 568
64. S. Schafers, R. Naunheim, A. Vijayan, and G. Tobin Incidence of hypoglycemia following insulin-based acute stabilization of hyperkalemia treatment J Hosp Med 7 2012 239 242
65. D. Czock, U. Aisenpreis, F.M. Rasche, and P.M. Jehle Pharmacokinetics and pharmacodynamics of lispro-insulin in hemodialysis patients with diabetes mellitus Int J Clin Pharmacol Ther 41 2003 492 497
66. P. Estep, and L. Efird Evaluation of hypoglycemia incidence and risk factors in patients treated with IV insulin aspart for hyperkalemia Endocrinol Diabetes Res 3 2015 1 4
67. A. Silvers, R.S. Swenson, J.W. Farquhar, and G.M. Reaven Derivation of a three compartment model describing disappearance of plasma insulin-131-I in man J Clin Invest 48 1969 1461 1469
68. M. Allon, R. Dunlay, and C. Copkney Nebulized albuterol for acute hyperkalemia in patients on hemodialysis Ann Intern Med 110 1989 426 429
69. A. Mandelberg, Z. Krupnik, S. Houri, and et al. Salbutamol metered-dose inhaler with spacer for hyperkalemia: how fast? How safe? Chest 115 1999 617 622
70. K.C. Schwarz, B.D. Cohen, G.D. Lubash, and A.L. Rubin Severe acidosis and hyperpotassemia treated with sodium bicarbonate infusion Circulation 19 1959 215 220
71. Z. Iqbal, and E.A. Friedman Preferred therapy of hyperkalemia in renal insufficiency: survey of nephrology training-program directors N Engl J Med 320 1989 60 61
72. R. Gutierrez, F. Schlessinger, J.R. Oster, and et al. Effect of hypertonic versus isotonic sodium bicarbonate on plasma potassium concentration in patients with end-stage renal disease Miner Electrolyte Metab 17 1991 297 302
73. A. Greenberg Hyperkalemia: treatment options Semin Nephrol 18 1998 46 57
74. R.H. Sterns, and A. Spital Disorders of internal potassium balance Semin Nephrol 7 1987 399 415
75. R.H. Sterns, M. Cox, P.U. Feig, and I. Singer Internal potassium balance and the control of the plasma potassium concentration Medicine 60 1981 339 354
76. D.S. Fraley, and S. Adler Correction of hyperkalemia by bicarbonate despite constant blood pH Kidney Int 12 1977 354 360
77. W. Meroney, and R. Herndon The management of acute renal insufficiency J Am Med Assoc 155 1954 877 883
78. H.S. Janjua, J.D. Mahan, H.P. Patel, and et al. Continuous infusion of a standard combination solution in the management of hyperkalemia Nephrol Dial Transplant 26 2011 2503 2508
79. M.A. Perazella Drug-induced hyperkalemia: old culprits and new offenders Am J Med 109 2000 307 314
80. C.G. Acker, J.P. Johnson, P.M. Palevsky, and A. Greenberg Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines Arch Intern Med 158 1998 917 924
81. B.F. Palmer Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system N Engl J Med 351 2004 585 592
82. T. Antoniou, T. Gomes, D.N. Juurlink, and et al. Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study Arch Intern Med 170 2010 1045 1049
83. C.A. Gentry, and A.T. Nguyen An evaluation of hyperkalemia and serum creatinine elevation associated with different dosage levels of outpatient trimethoprim-sulfamethoxazole with and without concomitant medications Ann Pharmacother 47 2013 1618 1626
84. N. Lam, M.A. Weir, D.N. Juurlink, and et al. Hospital admissions for hyperkalemia with trimethoprim-sulfamethoxazole: a cohort study using health care database codes for 393,039 older women with urinary tract infections Am J Kidney Dis 57 2011 521 523
85. H. Schepkens, R. Vanholder, J. Billiouw, and N. Lameire Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases Am J Med 110 2001 438 441
86. M.A. Weir, D.N. Juurlink, T. Gomes, and et al. Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study Clin J Am Soc Nephrol 5 2010 1544 1551
87. K.P. Tamirisa, K.D. Aaronson, and T.M. Koelling Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure Am Heart J 148 2004 971 978
88. P. Susantitaphong, K. Sewaralthahab, E.M. Balk, and et al. Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease: a meta-analysis Am J Hypertens 26 2013 424 441
89. M. Fralick, E.M. Macdonald, T. Gomes, et al. for the Canadian Drug Safety and Effectiveness Research Network Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population based study BMJ 349 2014 g6196
90. P. Feig, A. Shook, and R. Sterns Effect of potassium removal during hemodialysis on the plasma potassium concentration Nephron 27 1981 25 30
91. C. Kessler, J. Ng, K. Valdez, and et al. The use of sodium polystyrene sulfonate in the inpatient management of hyperkalemia J Hosp Med 6 2011 136 140
92. B.U. Agar, B.F. Culleton, R. Fluck, and J.K. Leypoldt Potassium kinetics during hemodialysis Hemodial Int 19 2015 23 32
93. A. Blumberg, H.W. Roser, C. Zehnder, and J. Muller-Brand Plasma potassium in patients with terminal renal failure during and after haemodialysis; relationship with dialytic potassium removal and total body potassium Nephrol Dial Transplant 12 1997 1629 1634
94. P. Bolasco, G. Concas, D. Steckiph, and et al. Simple model of intra-extracellular potassium kinetics and removal applied to constant and potassium-profiled dialysis J Nephrol 21 2008 384 393
95. K.C. Kao, C.C. Huang, Y.H. Tsai, and et al. Hyperkalemic cardiac arrest successfully reversed by hemodialysis during cardiopulmonary resuscitation: case report Chang Gung Med J 23 2000 555 559
96. J.L. Lin, P.S. Lim, M.L. Leu, and C.C. Huang Outcomes of severe hyperkalemia in cardiopulmonary resuscitation with concomitant hemodialysis Intensive Care Med 20 1994 287 290
97. J.L. Lin, and C.C. Huang Successful initiation of hemodialysis during cardiopulmonary resuscitation due to lethal hyperkalemia Crit Care Med 18 1990 342 343
98. R.A. DeFronzo Hyperkalemia and hyporeninemic hypoaldosteronism Kidney Int 17 1980 118 134
99. V. Carvalhana, L. Burry, and S.E. Lapinsky Management of severe hyperkalemia without hemodialysis: case report and literature review J Crit Care 21 2006 316 321
100. T. Dick, A. Raines, J. Stinson, and et al. Fludrocortisone is effective in the management of tacrolimus-induced hyperkalemia in liver transplant recipients Transplant Proc 43 2011 2664 2668
101. K.S. Kamel, J.H. Ethier, S. Quaggin, and et al. Studies to determine the basis for hyperkalemia in recipients of a renal transplant who are treated with cyclosporine J Am Soc Nephrol 2 1992 1279 1284
102. B. Evans, M. Milne, N.H. Jones, and H. Yellowlees Ion-exchange resins in the treatment of anuria Lancet 265 1953 791 795
103. R. Agarwal, R. Afzalpurkar, and J.S. Fordtran Pathophysiology of potassium absorption and secretion by the human intestine Gastroenterology 107 1994 548 571
104. C. Gruy-Kapral, M. Emmett, C.A. Santa Ana, and et al. Effect of single dose resin-cathartic therapy on serum potassium concentration in patients with end-stage renal disease J Am Soc Nephrol 9 1998 1924 1930
105. L. LePage Sodium polystyrene sulfonate for the treatment of mild hyperkalemia in chronic kidney disease: a randomized clinical trial Clin J Am Soc Nephrol 10 2015 2136 2142
106. G. Chernin, A. Gal-Oz, E. Ben-Assa, and et al. Secondary prevention of hyperkalemia with sodium polystyrene sulfonate in cardiac and kidney patients on renin-angiotensin-aldosterone system inhibition therapy Clin Cardiol 35 2012 32 36
107. B. Straube, N. Reaven, S. Funk, D. Little, R. Nee, K. Abbott, and et al. Cost utility analysis of sodium polystyrene sulfate vs. potential alternatives for chronic hyperkalemia. Clinical Nephrology, 2014;81:259-268 Clin Nephrol 83 2015 380 381
108. Z. Harel, S. Harel, P.S. Shah, and et al. Gastrointestinal adverse events with sodium polystyrene sulfonate (Kayexalate) use: a systematic review Am J Med 126 2013 264.e9 264.e24
109. K.D. Lillemoe, J.L. Romolo, S.R. Hamilton, and et al. Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: clinical and experimental support for the hypothesis Surgery 101 1987 267 272
110. M.A. Watson, T.P. Baker, A. Nguyen, and et al. Association of prescription of oral sodium polystyrene sulfonate with sorbitol in an inpatient setting with colonic necrosis: a retrospective cohort study Am J Kidney Dis 60 2012 409 416
111. I. Huang RLY5016: a novel, non-absorbed, therapeutic polymer for serum potassium control J Am Soc Nephrol 21 2010 482A 483A
112. D.A. Bushinsky Patiromer induces a rapid and sustain potassium lowering in CKD patients with hyperkalemia Kidney Int. 88 2015 1427 1433
113. B. Pitt, S.D. Anker, D.A. Bushinsky, and et al. PEARL-HF Investigators. Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial Eur Heart J 32 2011 820 828
114. M.R. Weir, G.L. Bakris, D.A. Bushinsky, et al. for the OPAL-HK Investigators Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors N Engl J Med 372 2015 211 221
115. G.L. Bakris, B. Pitt, M.R. Weir, et al. for the AMETHYST-DN Investigators Effect of patiromer on serum potassium level in patients with hyperkalemia and diabetic kidney disease: the AMETHYST-DN randomized clinical trial JAMA 314 2015 151 161
116. F. Stavros, A. Yang, A. Leon, and et al. Characterization of structure and function of ZS-9, a K+ selective ion trap PLoS One 9 2014 e114686
117. S.R. Ash, B. Singh, P.T. Lavin, and et al. A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient Kidney Int 88 2015 404 411
118. D.K. Packham, H.S. Rasmussen, P.T. Lavin, and et al. Sodium zirconium cyclosilicate in hyperkalemia N Engl J Med 372 2015 222 231
119. M. Kosiborod, H.S. Rasmussen, P. Lavin, and et al. Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial JAMA 312 2014 2223 2233
120. M. Kosiborod, W.F. Peacock, and D.K. Packham Sodium zirconium cyclosilicate for urgent therapy of severe hyperkalemia N Engl J Med 372 2015 1577 1578
121. N. El-Sherif, and G. Turitto Electrolyte disorders and arrhythmogenesis Cardiol J 18 2011 233 245
122. D. Charytan, and D.S. Goldfarb Indications for hospitalization of patients with hyperkalemia Arch Intern Med 160 2000 1605 1611
123. L.M. Einhorn, M. Zhan, V.D. Hsu, and et al. The frequency of hyperkalemia and its significance in chronic kidney disease Arch Intern Med 169 2009 1156 1162
124. J. Khanagavi, T. Gupta, W.S. Aronow, and et al. Hyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes Arch Med Sci 10 2014 251 257
125. G.M. McMahon, M.L. Mendu, F.K. Gibbons, and K.B. Christopher Association between hyperkalemia at critical care initiation and mortality Intensive Care Med 38 2012 1834 1842
126. R. Conway, D. Creagh, D.G. Byrne, and et al. Serum potassium levels as an outcome determinant in acute medical admissions Clin Med (Lond) 15 2015 239 243
127. D.J. Little, R. Nee, K.C. Abbott, and et al. Cost-utility analysis of sodium polystyrene sulfonate vs. potential alternatives for chronic hyperkalemia Clin Nephrol 81 2014 259 268
128. W.C. Winkelmayer Treatment of hyperkalemia: from "Hyper K+" strikeout to home run? JAMA 314 2015 129 130